Clopidogrel-induced qualitative changes in thrombus formation correlate with stent patency in injured pig cervical arteries

Thrombosis Research

Volumn 105, Issue 3, 2002, Pages 209-216

  Roussi, J ^a   Berge, N ^b   Bal Dit Sollier, C ^b   Bonneau, M ^c   Andre P ^b   Pignaud, G ^c   Wassef, M ^d   Baillard, O ^d   Herbert, J M ^e   Drouet, L ^b,c,d  

^a RAYMOND POINCARÉ HOSPITAL   (France)

^b Institut des Vaisseaux et du Sang   (France)

^c CEMAGREF   (France)

^d HÔPITAL LARIBOISIÈRE   (France)

^e SANOFI   (France)

Author keywords

Aspirin; Clopidogrel; Experimental model; Stent; Thrombus formation

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; LYSINE ACETYLSALICYLATE;

ANGIOPLASTY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY OCCLUSION; ARTERY THROMBOSIS; ARTICLE; BLEEDING TIME; CAROTID ARTERY; CONTROLLED STUDY; CORRELATION ANALYSIS; DEGRANULATION; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; HISTOPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; STENT; SWINE; THROMBOCYTE AGGREGATION; THROMBOGENESIS;

ANIMALS; ARTERIES; CERVIX UTERI; FEMALE; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; STENTS; SWINE; TICLOPIDINE;

EID: 0036473870     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(02)00027-0     Document Type: Article

References (31)

1. Collaborative overview of randomized trials of antiplatelet therapy: I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
2. Collaborative overview of randomized trials of antiplatelet therapy: II. Maintenance of vascular graft or arterial patency by antiplatelet therapy
3. Clopidogrel, a novel antiplatelet and antithrombotic agent
4. P2y(12), a new platelet ADP receptor, target of clopidogrel
5. Ticlopidine and clopidogrel
6. Aspirin as an antiplatelet drug
7. Comparative arterial antithrombotic activity of clopidogrel and acetylsalicylic acid in the pig
8. The antiaggregating and antithrombotic activity of ticlopidine is potentiated by aspirin in the rat
9. The antiaggregating and antithrombotic activity of clopidogrel is potentiated by aspirin in several experimental models in the rabbit
10. Clopidogrel inhibition of stent, graft, and vascular thrombogenesis with antithrombotic enhancement by aspirin in nonhuman primates
11. Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation
12. Atherosclerosis and thrombosis: Lessons from animal models
13. Platelet functions and haemostasis parameters in pigs, absence of side effects of a procedure of general anaesthesia
14. Optimal antagonism of GPIIb/IIIa favors platelet adhesion by inhibiting thrombus growth, an ex-vivo capillary flow chamber study in the guinea pig
15. An improved method for embedding hard tissue in polymethyl metacrylate
16. A practical and rapid method of histological processing for examination of coronary arteries containing metallic stents
17. Aspirin, heparin and fibrinolytic therapy in suspected acute myocardial infarction
18. Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of platelet IIb/IIIa inhibition in stenting investigators
19. Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: The GUSTO IV-ACS randomised trial
20. Results of a consecutive series of patients receiving only antiplatelet therapy after optimized stent implantation, comparison of aspirin alone versus combined ticlopidine and aspirin therapy
21. Aspirin and ticlopidine after routine coronary stenting, the gold standard as of 1999
22. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
23. Results of the CAPRIE trial, efficacy and safety of clopidogrel. Clopidogrel versus aspirin in patients at risk of ischaemic events
24. Clopidogrel and coronary stenting, what is the next question?
25. Clopidogrel, a review of its use in the prevention of atherothrombosis
26. Function of von Willebrand factor after crossed bone marrow transplantation between normal and von Willebrand disease pigs, effect on arterial thrombosis in chimeras
27. Effects of clopidogrel, aspirin and combined therapy in a porcine ex vivo model of high-shear induced stent thrombosis
28. Axial dependence of collagen-induced thrombus formation in flowing non-anticoagulated human blood. Anti-platelet drugs impair thrombus growth and increase platelet-collagen adhesion
29. Flow chambers and their standardization for use in studies thrombosis
30. Ultrastructural studies of platelet aggregates from human subjects receiving clopidogrel and from a patient with an inherited defect of an ADP-dependent pathway of platelet activation
31. Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans